DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / A•• A••••• F••• G•• L••
A•• A••••• F••• G•• L••
Aiming to overcome technical and funding barriers in antibiotic development and ensuring a sustainable pipeline of new antibiotics to fight superbugs.
venture manager, reported GAV $977M across 2 vehicles
Importance
30
moderate
Active deployment
0
low
Emerging
0
low
Completeness
69
high
Freshness
99
high
Research priority
5
low
Identity and regulatory footprint
- Headquarters
- Boston, MAadviserinfo.sec.gov
- Office address
- 225 FRANKLIN STREET, SUITE 1750, Boston, MA, 02110adviserinfo.sec.gov
- Business phone
- 617-850-2876adviserinfo.sec.gov
- Website
- a•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 31, 2026
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $977Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business phone
- 617-850-2876adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
- Sectors
- biotech, climate
- Stages
- not stated or not yet read
- Geography
- japan
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
Biotechnology 100%
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| A•• A••••• F••• L••• | Fund | unknown | Unknown | $725M Mar 27, 2024 | 12 | $0 of $1.3B | Dec 14, 2020 |
| A•• A••••• F•••• S••• | Fund | unknown | Unknown | $252M Mar 27, 2024 | 14 | $0 of $1.3B | Dec 14, 2020 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
17 current, 3 departed
H••••••••• R•••••••
AssociateVenture Associate
I••••••• S••••
AssociateVenture Associate
H•••• B••••••• S••••••
Founder or executiveChief Executive Officer · since Mar 1, 2021
H•••• B••••••• S••••••
Founder or executiveChief Executive Officer · since Mar 1, 2021
M••••• H••••••••
PartnerChief Investment Officer · since Aug 1, 2021
M••••• H••••••••
PartnerChief Investment Officer · since Aug 1, 2021
M••••• H••••••••
PartnerChief Investment Officer
C•••••• R•••••
Platform and operationsOffice Manager
D•••• C••••••••• H•••••••
Platform and operationsChief Compliance Officer, General Counsel And Chief Operating Officer · since Nov 1, 2022
D•••• C••••••••• H•••••••
Platform and operationsChief Compliance Officer, General Counsel And Chief Operating Officer · since Nov 1, 2022
D•••• H•••••••
Platform and operationsChief Legal Officer, Chief Compliance Officer, Chief Operating Officer
D•••••• M••••••
Platform and operationsCompliance Officer
J••• V••••••
Platform and operationsChief Financial Officer
J••• W•••••• V••••••
Platform and operationsChief Financial Officer · since Jun 1, 2023
J••• W•••••• V••••••
Platform and operationsChief Financial Officer · since Jun 1, 2023
J••••• G••
PrincipalPrincipal
C•••• L•••••
Vice presidentSenior Associate
3 departed (kept with end dates)
- M••••• B••• · Interim Chief Executive Officer · Dec 1, 2020 to Apr 30, 2021 Inference
- D•••• H••••••• · Chief Legal Officer, Chief Compliance Officer, Chief Operating Officer · ? to Sep 16, 2026 Inference
- E••••• M••••• · Head Of Finance And Operations · Jul 1, 2021 to Mar 30, 2023 Inference
Investments on record
2 edges, 2 companies, 2 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| V•••••• B••••••••• I••• | board seat | unknown · board | M••••• H•••••••• (strongly supported) | unknown | unknown | Aug 5, 2024 | Inference SEC EDGAR Form D data sets (quarterly) |
| E•••• T••••••••• I••• | board seat | unknown · board | M••••• H•••••••• (strongly supported) | unknown | unknown | Jun 26, 2024 | Inference SEC EDGAR Form D data sets (quarterly) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
11 dated events
- Sep 16, 2026D•••• H••••••• (Chief Legal Officer, Chief Compliance Officer, Chief Operating Officer) no longer on the team page of A•• A••••• F••• G•• L••Person leftPeopleInferenceD•••• H•••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Mar 30, 2023E••••• M••••• (Head Of Finance And Operations) no longer on Schedule A of A•• A••••• F••• G•• L••
- Dec 1, 2022J••• W•••••• V•••••• joined Schedule A of A•• A••••• F••• G•• L•• as Finance Director
- Nov 1, 2022D•••• C••••••••• H••••••• joined Schedule A of A•• A••••• F••• G•• L•• as Chief Compliance Officer, General Counsel And Chief Operating Officer
- Aug 1, 2021M••••• H•••••••• joined Schedule A of A•• A••••• F••• G•• L•• as Chief Investment Officer
- Jul 1, 2021E••••• M••••• joined Schedule A of A•• A••••• F••• G•• L•• as Head Of Finance And Operations
- Apr 30, 2021M••••• B••• (Interim Chief Executive Officer) no longer on Schedule A of A•• A••••• F••• G•• L••
- Mar 1, 2021H•••• B••••••• S•••••• joined Schedule A of A•• A••••• F••• G•• L•• as Chief Executive Officer
- Feb 12, 2021A•• A••••• F••• G•• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 12, 2021A•• A••••• F••• L••• first reported on Form ADV by A•• A••••• F••• G•• L•• (Venture Capital Fund), GAV $725,252,500Fund first reported on Form ADVFundsFactA•• A••••• F••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 12, 2021A•• A••••• F•••• S••• first reported on Form ADV by A•• A••••• F••• G•• L•• (Venture Capital Fund), GAV $251,620,000Fund first reported on Form ADVFundsFactA•• A••••• F•••• S•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $977M across 2 vehicles
Evidence
51 observations from 4 sources